Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31444252

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2020 Jan 15
First author
Li RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Clin Cancer Res. 2020 Jan 15;26(2):325-327. doi: 10.1158/1078-0432.CCR-19-2975.
    note
    Source null
    related pmid
    31641006
    relationship
    Comment in
  2. citation
    Clin Cancer Res. 2020 Jan 15;26(2):325-327. doi: 10.1158/1078-0432.CCR-19-2975.
    note
    Source null
    related pmid
    31641006
    relationship
    Comment on

Authors and identifiers

  1. name
    Li RJ
    type
    Author
  2. name
    Jin R
    type
    Author
  3. name
    Liu C
    type
    Author
  4. name
    Cao X
    type
    Author
  5. name
    Manning ML
    type
    Author
  6. name
    Di XM
    type
    Author
  7. name
    Przepiorka D
    type
    Author
  8. name
    Namuswe F
    type
    Author
  9. name
    Deisseroth A
    type
    Author
  10. name
    Goldberg KB
    type
    Author
  11. name
    Blumenthal GM
    type
    Author
  12. name
    Pazdur R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Li RJ
    type
    Author
  2. name
    Jin R
    type
    Author
  3. name
    Liu C
    type
    Author
  4. name
    Cao X
    type
    Author
  5. name
    Manning ML
    type
    Author
  6. name
    Di XM
    type
    Author
  7. name
    Przepiorka D
    type
    Author
  8. name
    Namuswe F
    type
    Author
  9. name
    Deisseroth A
    type
    Author
  10. name
    Goldberg KB
    type
    Author
  11. name
    Blumenthal GM
    type
    Author
  12. name
    Pazdur R
    type
    Author
bibliography ids
  1. nci-bib-c98e9f6f8d7bafb6a0060301
book metadata
content sha256
b6a1b87d238f75dba0accaebc5a79bc8f68d9bd90e5b5909626f904d7384747a
document type
citation
dois
  1. 10.1158/1078-0432.CCR-19-1255
electronic publication date
display
2019 Aug 23
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31444252
immutable id
pubmed:31444252@b6a1b87d238f75dba0accaebc5a79bc8f68d9bd90e5b5909626f904d7384747a
journal
abbreviation
Clin Cancer Res
issn electronic
1557-3265
issn print
1078-0432
issue
2
name
Clinical cancer research : an official journal of the American Association for Cancer Research
nlm unique id
9502500
pages
328-331
volume
26
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Clin Cancer Res. 2020 Jan 15;26(2):325-327. doi: 10.1158/1078-0432.CCR-19-2975.
    note
    Source null
    related pmid
    31641006
    relationship
    Comment in
  2. citation
    Clin Cancer Res. 2020 Jan 15;26(2):325-327. doi: 10.1158/1078-0432.CCR-19-2975.
    note
    Source null
    related pmid
    31641006
    relationship
    Comment on
outcomes validated
false
pmid
31444252
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
04d6594e1f958f75b3d66f92059c1cfe3c71c4a35214cfea668d6f6b78913c8f
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2020 Jan 15
precision
day
year
2020
publication types
  1. Journal Article
  2. Comment
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31444252/
title
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults.

Preserved source evidence · Not medical advice